1-12 of 12
Paolo Dellabona
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3596: Metabolic reprogramming of the tumor microenvironment to enhance the functionality of TCR-edited T cell in colorectal cancer and liver metastases

Alessia Potenza, Chiara Balestrieri, Martina Spiga, Luca Albarello, Federica Pedica, Arianna Ferrari, Oronza A. Botrugno, Barbara Camisa, Elena Tiziano, Camilla Sirini, Monica Casucci, Chiara Iozzi, Danilo Abbati, Ugo Elmore, Giulia Di Lullo, Giulia Casorati, Claudio Doglioni, Giovanni Tonon, Paolo Dellabona, Riccardo Rosati, Luca Aldrighetti, Paolo Monti, Eliana Ruggiero, Chiara Bonini
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3596.
https://doi.org/10.1158/1538-7445.AM2024-3596
Published: 22 March 2024
View article titled, Abstract 3596: Metabolic reprogramming of the tumor microenvironment to enhance the functionality of TCR-edited T cell in colorectal cancer and liver metastases
Journal Articles

Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma

Giuseppina Arbore, Luca Albarello, Gabriele Bucci, Marco Punta, Andrea Cossu, Lorella Fanti, Aurora Maurizio, Francesco Di Mauro, Vito Bilello, Gianluigi Arrigoni, Silvia Bonfiglio, Donatella Biancolini, Francesco Puccetti, Ugo Elmore, Luca Vago, Stefano Cascinu, Giovanni Tonon, Riccardo Rosati, Giulia Casorati, Paolo Dellabona
Journal: Cancer Research
Cancer Res (2023) 83 (17): 2873–2888.
https://doi.org/10.1158/0008-5472.CAN-23-0356
Published: 01 September 2023
View article titled, Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma
Open the PDF for Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract 902: Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells

Alessia Potenza, Chiara Balestrieri, Luca Albarello, Federica Pedica, Martina Spiga, Francesco Manfredi, Beatrice C. Cianciotti, Claudia De Lalla, Lorena Stasi, Elena Tassi, Silvia Bonfiglio, Giulia M. Scotti, Miriam Redegalli, Donatella Biancolini, Danilo Abbati, Fabio Simeoni, Dejan Lazarevic, Ugo Elmore, Guido Fiorentini, Giulia Di Lullo, Giulia Casorati, Claudio Doglioni, Giovanni Tonon, Paolo Dellabona, Riccardo Rosati, Luca Aldrighetti, Eliana Ruggiero, Chiara Bonini
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 902.
https://doi.org/10.1158/1538-7445.AM2023-902
Published: 04 April 2023
View article titled, Abstract 902: Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells
Journal Articles

Abstract 567: CRISPR/Cas9-mediated CD39 disruption can be combined with TCR editing in T cells to improve the adoptive T cell therapy of colorectal cancer

Alessia Potenza, Chiara Balestrieri, Luca Albarello, Federica Pedica, Lorena Stasi, Francesco Manfredi, Martina Spiga, Elena Tassi, Beatrice Claudia Cianciotti, Danilo Abbati, Ugo Elmore, Andrea Biondi, Luca Aldrighetti, Claudia De Lalla, Giulia Di Lullo, Paolo Dellabona, Eliana Ruggiero, Riccardo Rosati, Chiara Bonini
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 567.
https://doi.org/10.1158/1538-7445.AM2022-567
Published: 15 June 2022
View article titled, Abstract 567: CRISPR/Cas9-mediated CD39 disruption can be combined with TCR editing in T cells to improve the adoptive T cell therapy of colorectal cancer
Journal Articles

Abstract A83: Modifications of the bone marrow microenvironment in the transition from monoclonal gammopathy of undetermined significance to multiple myeloma in Vk*MYC mice.

Arianna Calcinotto, Matteo Grioni, Maria Teresa Sabrina Bertilaccio, Marta Chesi, Leif Bergsagel, Giulia Casorati, Paolo Dellabona, Matteo Bellone
Journal: Cancer Research
Cancer Res (2013) 73 (1_Supplement): A83.
https://doi.org/10.1158/1538-7445.TUMIMM2012-A83
Published: 02 April 2014
View article titled, Abstract A83: Modifications of the bone marrow microenvironment in the transition from monoclonal gammopathy of undetermined significance to multiple myeloma in Vk*MYC mice.
Journal Articles

CD4+ T Cells from Healthy Subjects and Colon Cancer Patients Recognize a Carcinoembryonic Antigen-specific Immunodominant Epitope

Gabriele Campi, Mariacristina Crosti, Giuseppe Consogno, Valeria Facchinetti, Bianca M. Conti-Fine, Renato Longhi, Giulia Casorati, Paolo Dellabona, Maria Pia Protti
Journal: Cancer Research
Cancer Res (2003) 63 (23): 8481–8486.
Published: 16 December 2003
View article titled, CD4<sup>+</sup> T Cells from Healthy Subjects and Colon Cancer Patients Recognize a Carcinoembryonic Antigen-specific Immunodominant Epitope
Open the PDF for CD4<sup>+</sup> T Cells from Healthy Subjects and Colon Cancer Patients Recognize a Carcinoembryonic Antigen-specific Immunodominant Epitope in another window
Journal Articles

The Cytotoxic T-Lymphocyte Response against a Poorly Immunogenic Mammary Adenocarcinoma Is Focused on a Single Immunodominant Class I Epitope Derived from the gp70 Env Product of an Endogenous Retrovirus

Antonio Rosato, Silvia Dalla Santa, Alessia Zoso, Sofia Giacomelli, Gabriella Milan, Beatrice Macino, Valeria Tosello, Paolo Dellabona, Pier-Luigi Lollini, Carla De Giovanni, Paola Zanovello
Journal: Cancer Research
Cancer Res (2003) 63 (9): 2158–2163.
Published: 01 May 2003
View article titled, The Cytotoxic T-Lymphocyte Response against a Poorly Immunogenic Mammary Adenocarcinoma Is Focused on a Single Immunodominant Class I Epitope Derived from the gp70 Env Product of an Endogenous Retrovirus
Open the PDF for The Cytotoxic T-Lymphocyte Response against a Poorly Immunogenic Mammary Adenocarcinoma Is Focused on a Single Immunodominant Class I Epitope Derived from the gp70 Env Product of an Endogenous Retrovirus in another window
Journal Articles

Tumor Pretargeting with Avidin Improves the Therapeutic Index of Biotinylated Tumor Necrosis Factor α in Mouse Models

Anna Gasparri, Monica Moro, Flavio Curnis, Angelina Sacchi, Stefano Pagano, Fabrizio Veglia, Giulia Casorati, Antonio G. Siccardi, Paolo Dellabona, Angelo Corti
Journal: Cancer Research
Cancer Res (1999) 59 (12): 2917–2923.
Published: 15 June 1999
View article titled, Tumor Pretargeting with Avidin Improves the Therapeutic Index of Biotinylated Tumor Necrosis Factor α in Mouse Models
Open the PDF for Tumor Pretargeting with Avidin Improves the Therapeutic Index of Biotinylated Tumor Necrosis Factor α in Mouse Models in another window
Journal Articles

Induction of Therapeutic T-Cell Immunity by Tumor Targeting with Soluble Recombinant B7-Immunoglobulin Costimulatory Molecules

Monica Moro, Anna Maria Gasparri, Stefano Pagano, Matteo Bellone, Paola Tornaghi, Fabrizio Veglia, Angelo Corti, Giulia Casorati, Paolo Dellabona
Journal: Cancer Research
Cancer Res (1999) 59 (11): 2650–2656.
Published: 01 June 1999
View article titled, Induction of Therapeutic T-Cell Immunity by Tumor Targeting with Soluble Recombinant B7-Immunoglobulin Costimulatory Molecules
Open the PDF for Induction of Therapeutic T-Cell Immunity by Tumor Targeting with Soluble Recombinant B7-Immunoglobulin Costimulatory Molecules in another window
Journal Articles

Tumor Cell Targeting with Antibody-Avidin Complexes and Biotinylated Tumor Necrosis Factor α

Monica Moro, Micaela Pelagi, Giulia Fulci, Giovanni Paganelli, Paolo Dellabona, Giulia Casorati, Antonio G. Siccardi, Angelo Corti
Journal: Cancer Research
Cancer Res (1997) 57 (10): 1922–1928.
Published: 01 May 1997
View article titled, Tumor Cell Targeting with Antibody-Avidin Complexes and Biotinylated Tumor Necrosis Factor α
Open the PDF for Tumor Cell Targeting with Antibody-Avidin Complexes and Biotinylated Tumor Necrosis Factor α in another window
Journal Articles

Particulate Naturally Processed Peptides Prime a Cytotoxic Response against Human Melanoma in Vitro

Maria Pia Protti, Maria Adele Imro, Angelo A. Manfredi, Giuseppe Consogno, Silvia Heltai, Cinzia Arcelloni, Matteo Bellone, Paolo Dellabona, Giulia Casorati, Claudio Rugarli
Journal: Cancer Research
Cancer Res (1996) 56 (6): 1210–1213.
Published: 01 March 1996
View article titled, Particulate Naturally Processed Peptides Prime a Cytotoxic Response against Human Melanoma <em>in Vitro</em>
Open the PDF for Particulate Naturally Processed Peptides Prime a Cytotoxic Response against Human Melanoma <em>in Vitro</em> in another window
Journal Articles

Immunizing and Curative Potential of Replicating and Nonreplicating Murine Mammary Adenocarcinoma Cells Engineered with Interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, Tumor Necrosis Factor α, Granulocyte-Macrophage Colony-stimulating Factor, and γ-Interferon Gene or Admixed with Conventional Adjuvants

Alessandra Allione, Manuela Consalvo, Patrizia Nanni, Pier Luigi Lollini, Federica Cavallo, Mirella Giovarelli, Marco Forni, Alberto Gulino, Mario P. Colombo, Paolo Dellabona, Hanno Hock, Thomas Blankenstein, Felicia M. Rosenthal, Bernd Gansbacher, Maria C. Bosco, Tiziana Musso, Luca Gusella, Guido Forni
Journal: Cancer Research
Cancer Res (1994) 54 (23): 6022–6026.
Published: 01 December 1994
View article titled, Immunizing and Curative Potential of Replicating and Nonreplicating Murine Mammary Adenocarcinoma Cells Engineered with Interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, Tumor Necrosis Factor α, Granulocyte-Macrophage Colony-stimulating Factor, and γ-Interferon Gene or Admixed with Conventional Adjuvants
Open the PDF for Immunizing and Curative Potential of Replicating and Nonreplicating Murine Mammary Adenocarcinoma Cells Engineered with Interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, Tumor Necrosis Factor α, Granulocyte-Macrophage Colony-stimulating Factor, and γ-Interferon Gene or Admixed with Conventional Adjuvants in another window